The conversion chart helps align equivalent doses, but most prescribers recommend starting semaglutide at a lower dose and titrating up regardless of previous tirzepatide dose to minimize gastrointestinal side effects during the transition
Understanding Semaglutide Semaglutide is an FDA-approved, GLP-1 receptor agonist designed for chronic weight management in adults struggling with obesity or being overweight with at least one weight-related condition
Effects of feet warming using bed socks on sleep quality and thermoregulatory responses in a cool environment
Ban K, Kim KH, Cho CK, Sauve M, Diamandis EP, Backx PH, Drucker DJ, Husain M: Glucagon-like peptide (GLP)-1(936)amide-mediated cytoprotection is blocked by exendin(939) yet does not require the known GLP-1 receptor
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): A substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Commitment to Long-Term Health and Wellness Our goal is to help you achieve lasting health and wellnessnot just temporary weight loss
